Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lomas

Showing results (11-20 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Clinical Investigation|December 5, 2002
Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapyDavid A Lomas, Ravi Mahadeva
Annual Review of Biochemistry|February 28, 2009
Conformational pathology of the serpins: themes, variations, and therapeutic strategiesBibek Gooptu, David A Lomas
Stem Cell Research & Therapy|February 21, 2012
Stem cell-based therapy for α₁-antitrypsin deficiencyS Tamir Rashid, David A Lomas
The International Journal of Biochemistry & Cell Biology|February 22, 2008
The molecular aetiology of the serpinopathiesMark J Davies, David A Lomas
Nature Reviews. Gastroenterology & Hepatology|March 9, 2017
Liver: Taking out the JuNK to treat α1-antitrypsin deficiencyS Tamir Rashid, David A Lomas
COPD|October 4, 2012
CC-16 as a biomarker in chronic obstructive pulmonary diseaseJennifer A Dickens, David A Lomas
The New England Journal of Medicine|January 5, 2002
Alpha1-antitrypsin deficiency--a model for conformational diseasesRobin W Carrell, David A Lomas
Nature Reviews. Genetics|October 3, 2002
Serpinopathies and the conformational dementiasDavid A Lomas, Robin W Carrell
Drug Design, Development and Therapy|October 4, 2011
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisJennifer A Dickens, David A Lomas
The New England Journal of Medicine|November 5, 2010
Alpha1-antitrypsin deficiency and autophagyStefan J Marciniak, David A Lomas
Pageof 29

Showing results (11-20 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Investigation|December 5, 2002
Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapyDavid A Lomas, Ravi Mahadeva
Annual Review of Biochemistry|February 28, 2009
Conformational pathology of the serpins: themes, variations, and therapeutic strategiesBibek Gooptu, David A Lomas
Stem Cell Research & Therapy|February 21, 2012
Stem cell-based therapy for α₁-antitrypsin deficiencyS Tamir Rashid, David A Lomas
The International Journal of Biochemistry & Cell Biology|February 22, 2008
The molecular aetiology of the serpinopathiesMark J Davies, David A Lomas
Nature Reviews. Gastroenterology & Hepatology|March 9, 2017
Liver: Taking out the JuNK to treat α1-antitrypsin deficiencyS Tamir Rashid, David A Lomas
COPD|October 4, 2012
CC-16 as a biomarker in chronic obstructive pulmonary diseaseJennifer A Dickens, David A Lomas
The New England Journal of Medicine|January 5, 2002
Alpha1-antitrypsin deficiency--a model for conformational diseasesRobin W Carrell, David A Lomas
Nature Reviews. Genetics|October 3, 2002
Serpinopathies and the conformational dementiasDavid A Lomas, Robin W Carrell
Drug Design, Development and Therapy|October 4, 2011
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisJennifer A Dickens, David A Lomas
The New England Journal of Medicine|November 5, 2010
Alpha1-antitrypsin deficiency and autophagyStefan J Marciniak, David A Lomas
Pageof 29